Literature DB >> 23897761

Ionic liquids as unique solvents in one-pot synthesis of 4-(n,2,2,2-tetranitroethylamino)-3-R-furazans.

Aleksei B Sheremetev1, Nataly S Aleksandrova, Nadezhda V Palysaeva, Marina I Struchkova, Vladimir A Tartakovsky, Kyrill Yu Suponitsky.   

Abstract

An efficient two-step one-pot protocol for the synthesis of N-nitrated trinitroethylamino furazans in an ionic liquid has been developed involving the condensation of aminofurazans with trinitroethanol and the N-nitration of an intermediate Mannich base. Trinitroethylnitramino derivatives have been synthesized and characterized by multinuclear NMR spectroscopy and X-ray crystallography. A role of the N,2,2,2-tetranitroethylamino group for stabilization of the high-density crystal-packing motif is described. The performance calculations gave detonation pressures and velocities for the furazan derivatives in a range of about 31-36 GPa and 8330-8745 ms(-1), respectively, which makes them competitive energetic materials. Furthermore, due to the positive oxygen balance, the compounds could be potential oxidizers for energetic formulations.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Mannich reaction; NMR spectroscopy; X-ray diffraction; heterocyles; ionic liquids

Year:  2013        PMID: 23897761     DOI: 10.1002/chem.201302126

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  3-Methyl-4-(2-phenyl-1,2,4-triazolo[1,5-a]pyrimidin-7-yl)furazan.

Authors:  Kyrill Yu Suponitsky; Victor M Chernyshev; Nadezhda V Palysaeva; Aleksei B Sheremetev
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-10-16

2.  Energetic Co-Crystal of a Primary Metal-Free Explosive with BTF. Ideal Pair for Co-Crystallization.

Authors:  Kyrill Yu Suponitsky; Ivan V Fedyanin; Valentina A Karnoukhova; Vladimir A Zalomlenkov; Alexander A Gidaspov; Vladimir V Bakharev; Aleksei B Sheremetev
Journal:  Molecules       Date:  2021-12-09       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.